About Us

Ramp Regulatory specializes in providing regulatory affairs and medicinal product development consulting services to biotech and pharma clients.

With a deep understanding of the regulatory landscape and extensive industry experience, we offer strategic regulatory affairs and product development advice, regulatory leadership, and hands-on authoring/submission support across all stages of medicinal product development from early stage research to registration in the US, EU and UK.

We are committed to high quality and timely service delivery, helping our clients navigate the complexities of regulatory affairs and achieve their regulatory goals.

Natalie Thomas (B. Biomed. Sc (Hons), PhD. RAC) is the founder of Ramp Regulatory and has over 15 years’ experience in regulatory affairs and medicinal product development, from early stage development to registration in the EU, US and UK.

She began her career as a research scientist in the Australian biotech sector, prior to spending the last ~15 years in delivering consulting services to small to medium size pharma/biotech in her roles at ERA Consulting, Voisin Consulting Life Sciences, Clinical Network Services and most recently as Director and Principal Consultant at Scendea Limited.

Her technical development focus has been in non-clinical and clinical development areas, working on medicinal products including ATMPs, biologics (e.g. mAb, bispecifics, ADC) and small molecules (both innovative and generic) in a wide range of therapeutic indications.

Our Founder

Ways of Working with Ramp Regulatory

PROJECT- OR ACTIVITY-BASED

Suited for projects or activities with a defined scope for support.

FEE FOR SERVICE

Hourly consulting contract with no retainer, suitable for small advisory activities.

PARTIAL FULL-TIME EQUIVALENT RETAINER

Retaining Ramp's services on a regular basis for ongoing support.